SCHEMBL31095207

SCHEMBL31095207

Fc1ncccc1/C=C\c1ccccc1Br

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD11B1 P28845 3/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.41
▸ TRIM24 O15164 1/20 0.40
▸ TRIM33 Q9UPN9 1/20 0.40
▸ NAPRT Q6XQN6 1/20 0.39
▸ NFE2L2 Q16236 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ NPC1 O15118 2/20 0.39
▸ RAB9A P51151 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ HSP90AA1 P07900 1/20 0.39
▸ PDGFRB P09619 1/20 0.38
▸ FGFR1 P11362 1/20 0.38
▸ FGFR3 P22607 1/20 0.38
▸ CCR3 P51677 1/20 0.36
▸ RELA Q04206 1/20 0.35
▸ IKBKB O14920 1/20 0.35
▸ DYRK2 Q92630 1/20 0.35
▸ GRM4 Q14833 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31095224 1.00 HSD11B1 (0.43) HSD11B1SMN1; SMN2TRIM24TRIM33NAPRT
SCHEMBL8486922 0.86 NAPRT (0.48) TRIM24TRIM33NAPRTNFE2L2MEN1
SCHEMBL8486928 0.86 NAPRT (0.48) TRIM24TRIM33NAPRTNFE2L2MEN1
SCHEMBL31095221 0.83 NFE2L2 (0.42) TRIM24TRIM33NAPRTNFE2L2NPC1
SCHEMBL31095177 0.83 NFE2L2 (0.42) TRIM24TRIM33NAPRTNFE2L2RELA
SCHEMBL31095230 0.82 NFE2L2 (0.47) SMN1; SMN2TRIM24TRIM33NAPRTNFE2L2
SCHEMBL31095227 0.77 CSNK1A1 (0.38) TRIM24TRIM33NAPRT
SCHEMBL1751871 0.77 HSD11B1 (0.62) HSD11B1SMN1; SMN2NFE2L2MEN1NPC1
SCHEMBL297691 0.77 HSD11B1 (0.62) HSD11B1SMN1; SMN2NFE2L2MEN1NPC1
SCHEMBL31613215 0.77 HSD11B1 (0.62) HSD11B1SMN1; SMN2NFE2L2MEN1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4680602-A1 HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS Miralinc Pharma, Inc. (US) 2026-01-21 — — EP disclosed
WO-2024192237-A1 HETEROCYCLIC COMPOUNDS AS SELECTIVE HDAC6 INHIBITORS MIRALINC PHARMA, INC. (US) 2024-09-19 — — WO disclosed
Send feedback